Device therapy to modulate the autonomic nervous system to treat heart failure

Area of Science:

• Cardiology
• Neuroscience
• Biomedical Engineering

Background:

• Heart failure (HF) is a major cause of morbidity and mortality, often resulting from complex heart disease.
• Alterations in the heart's autonomic nervous system interaction are characteristic of advanced HF.
• Current treatments, while advanced, do not prevent progression to end-stage HF for many patients.

Purpose of the Study:

• To explore novel device-based therapies for heart failure.
• To investigate the potential of neuromodulation targeting the neuro-cardiac axis.
• To assess the efficacy of these interventions in experimental and human heart failure models.

Main Methods:

• Review of existing literature on neuro-cardiac axis in heart failure.
• Analysis of experimental studies on device-based neuromodulation (spinal cord stimulation, vagal nerve stimulation, baroreflex modulation).
• Overview of ongoing human clinical trials evaluating safety and efficacy.

Main Results:

• Experimental models demonstrate that device-based neuromodulation can improve cardiac function in heart failure.
• Specific modalities include spinal cord stimulation, vagal nerve stimulation, and baroreflex modulation.
• Human trials are actively investigating these promising therapeutic approaches.

Conclusions:

• Device-based neuromodulation represents a promising frontier in heart failure treatment.
• Targeting the neuro-cardiac axis offers a new strategy for managing advanced and end-stage heart failure.
• Further clinical evaluation is crucial to establish the role of these therapies in patient care.